Australasian Ocular Melanoma Alliance Virtual Summit 2025

The Australasian Ocular Melanoma Alliance Virtual Summit is Australia's premier event dedicated to ocular melanoma, hosted annually by Melanoma and Skin Cancer Trials in partnership with the Australasian Ocular Melanoma Alliance (AOMA). This one-day, online gathering is a key platform for collaboration, learning, and advocacy in the field of this rare and aggressive cancer.

Date: Saturday 8 November 2025
Time: 10am - 4pm
Location: Virtual Event

Data Processing Consent

We are committed to protecting the privacy of all personal data you provide us for the Australasian Ocular Melanoma Alliance Virtual Summit 2025.

Please review the Data Processing Consent Statement before agreeing below.

option required

Registration

Please select your registration type below:

Contact Details

Please complete your contact details below:

Please select your discipline (Maximum of 2)

Are you of Aboriginal and/or Torres Strait Islander origin?

How did you find out about the AOMA Summit?

Are you a member of the Australian Ocular Melanoma Alliance (AOMA)?

Do you wish to claim CPD hours via Optometry Australia?

Are you interested in future events held by MASC Trials or AOMA?

Terms and Conditions

Thank You

Thank you for registering to attend the Australasian Ocular Melanoma Alliance Virtual Summit. Please check your email for a confirmation, if you have not received this confirmation email please contact our event organisers on 1300 878 815.

Our event organisers will be in touch closer to the event with details to access the virtual event on the day.

 

We are using a temporary cookie to streamline your experience. No personal data is stored and the cookie is removed once you complete your registration.

Your Browser Settings have Cookies Disabled

This site requires a temporary cookie to streamline your experience. No personal data is stored and the cookie will be removed once you complete your registration. Please enable cookies in your browser and refresh this page.